“…[41] Consistently, many studies implied that Tiam1 overexpression exhibited an accelerative effect in regulating malignant cell proliferation in a wide range of cancers, including hepatocellular carcinoma, [42–44] oral cancer, [45] lung cancer, [35] esophageal cancer, [46,47] pancreatic cancer, [13,48] ovarian cancer, [49] cervical cancer, [33,50] colon cancer, [51–54] gastric cancer, [55] osteosarcoma, [56,57] nasopharyngeal cancer, [14] laryngeal cancer, [31] and cholangiocarcinoma. [58] Besides, lots of studies indicated that upregulation of Tiam1 could protect malignant cells from apoptotic death in esophageal cancer, [46,47] cervical cancer, [50] laryngeal cancer, [31] retinoblastoma, [59] and colon cancer. [54] Third, a few recent studies demonstrated that Tiam1 was able to promote of angiogenesis cervical [33] and lung cancer.…”